Sitemap
Pages
- About Us
- Careers
- Contact us
- CuraCloud
- CuraRad-ICH
- DEEPVESSEL Angio
- DEEPVESSEL CARS
- DEEPVESSEL FFR
- DEEPVESSEL FFR Demo Request
- Diagnostic Solutions
- Forward-looking Statements Disclaimer
- Glossary
- Home
- KM-Styleguide-Website
- News
- Privacy Policy
- Professionals
- Publications
- R&D Pipeline
- Sitemap
- Solutions Inquiry
- Terms of Use
- Treatment Solutions
Posts
All News
- Cardiovascular Imaging AI Applications
- Chest X-Ray and Medical Imaging AI
- Clinical Significance and Research Progress of Non-invasive CT-FFR
- Coronary CTA Reimbursement: Opportunities & Challenges
- COVID-19 Research Results Published in Radiology
- CuraCloud and Clario Announce Co-Development Agreement
- CuraCloud Enhances CT Triage Capabilities to Include Pneumonia Associated with COVID-19
- CuraCloud Receives FDA Clearance for ICH Triage Solution
- CuraCloud Works with NVIDIA to Bring Advanced AI Tools to Healthcare
- CuraRad-ICH Joins Nuance AI Marketplace for Diagnostic Imaging
- Deep Learning-based CT-FFR Reduces the Need for Invasive Coronary Angiography
- DeepVessel 3D Visualization Processing Software Receives Regulatory Approval in China
- DEEPVESSEL FFR Implemented in Civil Aviation General Hospital
- DEEPVESSEL FFR is Approved for Clinical Use in China
- DEEPVESSEL FFR Receives CE Mark
- Dr. Kunlin Cao Named to 2021 Forbes China Up-and-Coming Businesswomen List
- EACVI Best of Imaging: Advances in Cardiac CT
- ESC Updated Guidelines on Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation
- Innovation Fast and Slow: The Case for Coronary CT Angiography
- Keya Medical and Shunde Hospital of Southern Medical University Bring Non-invasive CT-FFR to Patients
- Keya Medical Attends 10th Summit on Scientific and Technological Innovation in Major Disease Control
- Keya Medical Awarded China Health Innovation Award at 2020 DEMO China
- Keya Medical Closes $30 Million Series C Funding Round Led by IDG Capital
- Keya Medical Delivers Academic Lecture at Northern Jiangsu People’s Hospital
- Keya Medical Partners with Luohe Sixth People’s Hospital
- Keya Medical Presents at the Second Congress of China AI in Medical Imaging Conference
- Keya Medical Raises $46M in Series D Round
- Keya Medical Raises Over $20 Million in Series B+ Financing Round
- Keya Medical Receives Strategic Investment
- Keya Medical Selected in Top 100 Medical Companies of the Future
- Keya Medical Wins 2020 Ernst & Young Fudan China’s Most Promising Company Award
- Moving Toward a Coronary CTA-first Strategy: Current Evidence, Guidelines, & Recommendations
- NMPA Regulatory Policy for Medical AI Solutions
- Putting the Spotlight on Women’s Hearts: Cardiovascular Disease in Women
- QICCD 2020: Diagnosis and Treatment of Cardiovascular Disease
- Regulating Artificial Intelligence in Radiological Imaging
- SIIM 2020 Checkpoint
- Simultaneous Classification & Segmentation of Intracranial Hemorrhage
- The Big Data Boom in Chest Radiography
- The Evolving Role of AI: Generalizability, Domain Shift, and Localization
- The Value of Deep Learning-based CT-FFR in Detecting Coronary Stenosis & Predicting Outcomes
- Understanding the Turnaround Time Effects of an AI-based Prioritization System for Intracranial Hemorrhage
- Virtual Medical AI Events in November
- Will New Value-based Care Regulations Spark Innovation?
Blog
- Cardiovascular Imaging AI Applications
- Chest X-Ray and Medical Imaging AI
- Clinical Significance and Research Progress of Non-invasive CT-FFR
- Coronary CTA Reimbursement: Opportunities & Challenges
- EACVI Best of Imaging: Advances in Cardiac CT
- ESC Updated Guidelines on Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation
- Innovation Fast and Slow: The Case for Coronary CT Angiography
- Keya Medical Attends 10th Summit on Scientific and Technological Innovation in Major Disease Control
- Keya Medical Delivers Academic Lecture at Northern Jiangsu People’s Hospital
- Keya Medical Presents at the Second Congress of China AI in Medical Imaging Conference
- Moving Toward a Coronary CTA-first Strategy: Current Evidence, Guidelines, & Recommendations
- NMPA Regulatory Policy for Medical AI Solutions
- QICCD 2020: Diagnosis and Treatment of Cardiovascular Disease
- Regulating Artificial Intelligence in Radiological Imaging
- SIIM 2020 Checkpoint
- Simultaneous Classification & Segmentation of Intracranial Hemorrhage
- The Big Data Boom in Chest Radiography
- The Evolving Role of AI: Generalizability, Domain Shift, and Localization
- The Value of Deep Learning-based CT-FFR in Detecting Coronary Stenosis & Predicting Outcomes
- Understanding the Turnaround Time Effects of an AI-based Prioritization System for Intracranial Hemorrhage
- Virtual Medical AI Events in November
- Will New Value-based Care Regulations Spark Innovation?
Investors
Press
- COVID-19 Research Results Published in Radiology
- CuraCloud and Clario Announce Co-Development Agreement
- CuraCloud Enhances CT Triage Capabilities to Include Pneumonia Associated with COVID-19
- CuraCloud Receives FDA Clearance for ICH Triage Solution
- CuraCloud Works with NVIDIA to Bring Advanced AI Tools to Healthcare
- CuraRad-ICH Joins Nuance AI Marketplace for Diagnostic Imaging
- DeepVessel 3D Visualization Processing Software Receives Regulatory Approval in China
- DEEPVESSEL FFR Implemented in Civil Aviation General Hospital
- DEEPVESSEL FFR is Approved for Clinical Use in China
- DEEPVESSEL FFR Receives CE Mark
- Dr. Kunlin Cao Named to 2021 Forbes China Up-and-Coming Businesswomen List
- Keya Medical and Shunde Hospital of Southern Medical University Bring Non-invasive CT-FFR to Patients
- Keya Medical Awarded China Health Innovation Award at 2020 DEMO China
- Keya Medical Closes $30 Million Series C Funding Round Led by IDG Capital
- Keya Medical Partners with Luohe Sixth People’s Hospital
- Keya Medical Raises $46M in Series D Round
- Keya Medical Raises Over $20 Million in Series B+ Financing Round
- Keya Medical Receives Strategic Investment
- Keya Medical Selected in Top 100 Medical Companies of the Future
- Keya Medical Wins 2020 Ernst & Young Fudan China’s Most Promising Company Award